[1]
L. Yevsieieva, A. Geleverya, N. Koval, A. Kyrychenko, S. M. Kovalenko, and O. N. Kalugin, “Ecological optimization of synthesis routes for a new non covalent inhibitor of SARS CoV 2 main protease as a promising active pharmaceutical ingredient”, ScienceRise: Pharmaceutical Science, no. 6 (58), pp. 4–13, Nov. 2025.